Recruiting
Phase 2
Phase 3

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Sponsor:

Paul R Fortin

Code:

NCT05236491

Conditions

Rheumatoid Arthritis

Autoimmune Rheumatologic Disease

Systemic Lupus Erythematosus

Systemic Vasculitis

Systemic Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

COVID-19 vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Paul R Fortin on 2023-01-17.